Johnson and Johnson Newswire

Comprehensive Real-Time News Feed for Johnson and Johnson.

Results 1 - 20 of 3,289 in Johnson and Johnson

  1. Product recalls: The top 5, in honour of Tesco's recall of apple...Read the original story w/Photo

    2 hrs ago | This Is North Devon

    WE take a look back at the top five products to be recalled over the years, in honour of Tesco's recall of their No Added Sugar Double Concentrate Apple and Blackcurrant Squash. 1)Thirteen people died from taking Tylenol in 1982 in Chicago after somebody tampered with the bottles by adding potassium cyanide.

    Comment?

  2. Trial finds GSK Ebola shot is safe and provokes immune responseRead the original story w/Photo

    2 hrs ago | DNA India

    First results from a human trial of an Ebola vaccine from GlaxoSmithKline show it is safe and generates an immune response, scientists said on Wednesday, but larger trials are needed to see if it protects and if a booster is needed. First results from a human trial of an Ebola vaccine from GlaxoSmithKline show it is safe and generates an immune response, scientists said on Wednesday, but larger trials are needed to see if it protects and if a booster is needed.

    Comment?

  3. Clinovo Hosts Its 10th Session of Silicon Valley BioTalks on "Paper...Read the original story w/Photo

    4 hrs ago | PRWeb

    Clinical trials experts from Clinovo , Elixir Medical, and Digitaliza TXT discuss "Paper Trials vs. EDC Solutions" on February 25th, 2015 at HP headquarters in Palo Alto, CA The 10th session of the Silicon Valley BioTalks will take place on February 25th at 5:30-7:30pm in HP headquarters in Palo Alto, CA. The panelists comprised of clinical trials experts from life science companies and Clinical Research Organizations will discuss the topic "Paper Trials vs. EDC Solutions - Benefits, Challenges, and Best Practices".

    Comment?

  4. Xarelto Attorney News: JPML Consolidates National Xarelto LawsuitsRead the original story w/Photo

    4 hrs ago | PRWeb

    Attorneys representing clients nationwide in Xarelto lawsuits for internal bleeding and hemorrhagic stroke allegedly linked to Xarelto are currently accepting new claims; eligible persons are entitled to no-cost, no-obligation Xarelto lawsuit reviews with the Onder Law Firm. In its most recent Hearing Session, the Judicial Panel on Multidistrict Litigation approved the consolidation of national Xarelto lawsuits, according to court documents.

    Comment?

  5. Former FDA chief testifies for plaintiff in Risperdal caseRead the original story w/Photo

    6 hrs ago | Philly.com

    David Kessler, the former U.S. Food and Drug Administration commissioner, testified Wednesday that as a pediatrician, it "certainly is a red flag to me" that a Janssen Pharmaceuticals Inc. study of the use of its antipsychotic drug Risperdal in young children and adolescents, mainly boys, showed high rates of breast growth. Kessler was FDA commissioner from 1990 to 1997, when Janssen, a subsidiary of Johnson & Johnson, received approval in 1993 for the drug to be prescribed to adults with psychosis.

    Comment?

  6. Ebola vaccine trial a successRead the original story

    8 hrs ago | Australian Broadcasting Corporation

    ELEANOR HALL: An Ebola vaccine has passed initial safety tests at Oxford University, and now thousands of doses are being sent to West Africa for wider trials. The lead researcher, Professor Adrian Hill from Oxford University's Jenner Institute, says more than 10,000 people will now be tested in Liberia, and then more hopefully in Sierra Leone and Guinea.

    Comment?

  7. Catherine Sawyer, a 2001 graduate of Hunterdon Central High School, is engagedRead the original story w/Photo

    10 hrs ago | NJ.com

    Bruce and Marcia Sawyer of Whitehouse Station are proud to announce the engagement of their daughter Catherine Melissa Sawyer to Robert James Rowe, son of Ronald and Rebecca Rowe of Honesdale, Pa. Pictured is Robert Rowe and Catherine Sawyer.

    Comment?

  8. Reports: Man Charged After Hidden Bathroom Camera Is Found In Johnson & Johnson Chelsea OfficeRead the original story w/Photo

    10 hrs ago | CBS Local

    CBS 2 CBS 2 is part of CBS Television Stations, a division of CBS Corp. and one of the largest network-owned station groups in the country. Latest Videos Eye On New York Dining Deals Tony's Table Links [...] WCBS 880 WCBS Newsradio 880 is one of America's most listened to radio stations providing news and information on the AM dial in New York for 45 years.

    Comment?

  9. Ex-FDA chief testifies against J&J drugRead the original story w/Photo

    12 hrs ago | Philly.com

    David Kessler, the former U.S. Food and Drug Administration commissioner, testified Wednesday that as a trained pediatrician it "certainly is a red flag to me" that a Janssen Pharmaceutical study of the use of the antipsychotic drug Risperdal in children and adolescents, mainly boys, showed higher-than-known rates of breast growth. Kessler was FDA commissioner from 1990 to 1997, when Janssen, the pharmaceutical subsidiary of Johnson & Johnson, received approval in 1993 for the drug to be prescribed to adults with pychosis.

    Comment?

  10. Police: Johnson & Johnson worker hid bathroom cameraRead the original story w/Photo

    14 hrs ago | UPI

    New Jersey-based company Johnson & Johnson produces numerous products one might expect to find in a bathroom, but a pinhole spy camera is not among them. New York police said a Johnson & Johnson contractor was arrested on suspicion of placing a hidden camera in a company bathroom to record people using the toilet.

    Comment?

  11. Johnson & Johnson: Beyond The Q4 HeadlinesRead the original story w/Photo

    15 hrs ago | Seeking Alpha

    Dozens of new products coming from all three business segments should contribute to growth going forward, with many other consumer and medical device products having been recently released. The company remains a market leader, with 70% of sales coming from products with either a #1 or #2 market share position.

    Comment?

  12. Fed stays 'patient,' but rate hikes are comingRead the original story w/Photo

    16 hrs ago | KSBW-TV

    The Federal Reserve said it will remain "patient" and not rush to boost interest rates. But the writing is on the wall.

    Comment?

  13. Tau-Based Vaccines Could Transform Early Alzheimer's Disease Treatment, Says GlobalData AnalystRead the original story w/Photo

    17 hrs ago | Pharmaceutical Processing

    While current treatments for Alzheimer's Disease are only able to ease symptoms temporarily, tau-based vaccines may offer a new and more effective way to treat AD in the early course of the disease, says an analyst with research and consulting firm GlobalData. According to Kyle S. Nicholson, PharmD, GlobalData's Analyst covering Neurology, tau-based therapies for AD have traditionally been overlooked in favor of passive beta amyloid immunotherapies, such as Eli Lilly's solanezumab and Roche's gantenerumab and crenezumab.

    Comment?

  14. There's an Ebola Vaccine in Africa. Now What?Read the original story w/Photo

    17 hrs ago | National Journal

    A scanning electron micrograph of the Ebola virus budding from the surface of a Vero cell . ), was late for our phone conference.

    Comment?

  15. Not Every Company Is Getting Hurt by the Strong U.S. DollarRead the original story w/Photo

    18 hrs ago | TheStreet.com

    NEW YORK -- The U.S. dollar's continuing strength has been taking a major bite out of the sales and earnings of many big U.S. companies that do lots of business abroad. But not all companies are as vulnerable to the dollar's moves.

    Comment?

  16. Avon facing reality that it may sell for half its' worthRead the original story w/Photo

    19 hrs ago | Cosmetics Design

    Despite Avon's stocks rising of late, the brand's current trading price is fuelling rumours of a potential deal with private-equity firm TPG, which could see it go for half its worth. Speculation that the global cosmetics brand may be willing to take such a hit comes as a surprise to industry analysts, as Avon had rejected perfume maker Coty's offer to acquire the brand for $10.7bn back in 2012.

    Comment?

  17. New Market Research Report: Synthes, Inc. - Medical Equipment - Deals and Alliances ProfileRead the original story

    20 hrs ago | PR-inside.com

    It carries out the development, production and marketing of instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the skeleton and its soft tissues. The company's product categories include treatments related to trauma, spine, cranio-maxillofacial , biomaterials and power tools.

    Comment?

  18. Former Coty Exec Named CEO at Illuminage BeautyRead the original story w/Photo

    Yesterday | HAPPI/Household & PP Industry

    Cleary was most recently president of Coty Beauty Americas. "Leading Iluminage Beauty into its next growth phase is an exciting opportunity," said Cleary.

    Comment?

  19. Applied Molecular Transport Announces Research And Development...Read the original story

    Yesterday | BioSpace

    Applied Molecular Transport's technology, TRANSINT, enables the development of oral biopharmaceuticals and RNA therapeutics for local gastrointestinal targeting or systemic release. Under the terms of the agreement, facilitated by Johnson & Johnson Innovation, , Applied Molecular Transport is eligible to receive upfront license fees, support for research activities conducted in collaboration with Janssen immunology scientists, and milestone payments upon achievement of defined development, regulatory and commercialization milestones, plus tiered royalties on worldwide sales.

    Comment?

  20. NYT: Subprime Auto-Loan Bonds: A Disaster in the Making?Read the original story w/Photo

    Tuesday | News Max

    Institutional investors are going nuts over subprime auto-loan bonds, enticed by their hefty yields in a low interest-rate environment. But some experts are worried that the investment spree is going overboard and could end in disaster, as strapped borrowers default on their loans.

    Comment?